ICTS: Site n-Alysis

Site n-Alysis™ allows you to identify and qualify potential study sites based on surrounding patient population as well as therapeutic specialty, investigator experience, trial volume and more.

What Is Site n-Alysis™?
Site n-Alysis is a proprietary process that models patient prevalence to find sites and potential site locations in more than 60 countries that have access to the patients you need for your clinical trial.

Sites with access to more subjects can be more successful enrollers.

Once prospective sites have been identified based on their access to patients, the Site n-Alysis process then creates site profiles to compare factors such as investigator experience, trial volume, ability to accept new trials, IRB status, and much more.

The Site n-Alysis process delivers market and national maps of sites including prevalence and geographic features such as highways, public transportation, rivers, etc., and may include investigator interview summaries.

How Does Site n-Alysis Work?
Using its proprietary epidemiological process, ICTS creates a national prevalence model for your protocol for each country under consideration.
ICTS models the patient populations at local levels. Our analysis can be done at the city, county, Zip code or census tract level (or equivalent per country).
If there is no existing site list to evaluate, ICTS identifies potential sites in the areas with high patient populations, and screens them according to the requirements of the protocol.
To allow our clients to compare sites, ICTS scores sites based on criteria that are most relevant to the study and most predictive of their success.
ICTS can deliver a variety of reports, maps, tables and site interview summaries to allow clients to make informed site selections.

1. Site n-Alysis
TM
Identify and Qualify Sites
Gregg Sweet, MBA
VP Strategy and Development
[email protected]
o. [phone]
c. [phone]
www.icts.us

2. Who Is ICTS?
Integrated Clinical Trial Services
Pre-Trial
Preparation
Recruitment/
Enrollment
Retention/
Compliance
Enrollment
Success
ICTS is a Clinical Trials Support Company that specializes in
achieving superior results in research studies by building and
maintaining stronger connections throughout the entire clinical trial
process. Our innovative and customized communication models
provide the foundation for higher quality data and results.

3. Pre-Trial
Preparation
Recruitment/
Enrollment
Retention/
Compliance
Enrollment
Success
Site n-Alysis™
Identify / Qualify

4. Site n-Alysis™
Identify / Qualify
Pre-Trial
Preparation
Recruitment/
Enrollment
Retention/
Compliance
Enrollment
Success
Site n-Alysis™ allows you to identify and qualify potential study
sites based on surrounding patient population as well as therapeutic
specialty, investigator experience, trial volume and more.

Mapping is an important part of the analysis because it can also
uncover barriers such as water features that would not be evident in
a spreadsheet.

5. Site n-Alysis™
Identify / Qualify
Pre-Trial
Preparation
Recruitment/
Enrollment
Retention/
Compliance
Enrollment
Success
What Is Site n-Alysis™?

Site n-Alysis is a proprietary process that models patient prevalence to find sites
and potential site locations in more than 60 countries that have access to the patients
you need for your clinical trial.

Sites with access to more subjects can be more successful enrollers.

Once prospective sites have been identified based on their access to patients, the
Site n-Alysis process then creates site profiles to compare factors such as
investigator experience, trial volume, ability to accept new trials, IRB status, and
much more.

The Site n-Alysis process delivers market and national maps of sites including
prevalence and geographic features such as highways, public transportation, rivers,
etc., and may include investigator interview summaries.

6. Site n-Alysis™
Identify / Qualify
Pre-Trial
Preparation
Recruitment/
Enrollment
Retention/
Compliance
Enrollment
Success
How Does Site n-Alysis Work?

Using its proprietary epidemiological process, ICTS creates a national prevalence
model for your protocol for each country under consideration.

ICTS models the patient populations at local levels and our analysis can be done at
the city, county, Zip code or census tract level (or equivalent per country). If there is
no existing site list to evaluate, ICTS identifies potential sites in the areas with high
patient populations, and screens them according to the requirements of the
protocol.

To allow our clients to compare sites, ICTS scores sites based on criteria that are
most relevant to the study and most predictive of their success. ICTS can deliver
a variety of reports, maps, tables and site interview summaries to allow clients to
make informed site selections.

7. Site n-Alysis™
Identify / Qualify
Pre-Trial
Preparation
Recruitment/
Enrollment
Retention/
Compliance
Enrollment
Success
Prevalence Density

This map illustrates the effects
of factoring for prevalence
density. Because many
diseases tend to conform to the
general population, evaluating
the prevalence on a per capita
basis can often help identify
markets that are likely to be
more efficient for both site
selection as well as advertising
support.

8. Site n-Alysis™
Identify / Qualify
Pre-Trial
Preparation
Recruitment/
Enrollment
Retention/
Compliance
Enrollment
Success
Prequalified Sponsors

Study sponsors are able to
prequalify sites based on the
unique requirements of the
study protocol. Sites are then
scored with regard to how well
they appear to conform to the
study requirements, including
adjacent patient population
(adjusted for inclusion /
exclusion criteria), investigator
profiles, comparable trial
volume, IRB status, and more.

9. Site n-Alysis™
Identify / Qualify
Pre-Trial
Preparation
Recruitment/
Enrollment
Retention/
Compliance
Enrollment
Success
Population Datasets

Site n-Alysis is supported by
thousands of population
datasets as well as in-country
experts worldwide. Brazil is
just one of over 60 countries
for which we are able to
provide in-depth analysis.

10. Site n-Alysis™
Identify / Qualify
Pre-Trial
Preparation
Recruitment/
Enrollment
Retention/
Compliance
Enrollment
Success
Overlapping Catchment

This map illustrates the results
of comparing three current and/
or proposed clinical trial
research sites in the San
Francisco-Oakland area. The
analysis is extended to consider
the effects of overlapping
catchment areas, i.e. the
degree to which multiple sites
are competing for the same
patients.

11. For more information contact:

Gregg Sweet, MBA
VP Strategy and Development

[email protected]
o. [phone]
c. [phone]
f. [phone]
www.icts.us